AIDX Could Be Next Household Name AI Company

For weeks we have heard CNBC complaining that we "need new names" of companies to play in the AI space because everybody is sick of Nvidia (NVDA) and Super Micro (SMCI), which have little/no remaining upside.

In all likelihood, we won't see CNBC or other mainstream media outlets begin covering Healwell AI (TSX: AIDX) until later this month when its market cap gets into the $500M-$1B range. At that point, when the mainstream media begins actively discussing AIDX, it could quickly become the new household name publicly traded AI company. If AIDX soars to a $2-4B market cap, we would consider it to be a bubble, but it wouldn't be out of line in comparison to Ambience Healthcare (one of many examples we can give you), which after raising $70M in its February Series B round has an implied enterprise value of at least 100X revenue. We know AIDX already has a revenue run rate of $20M on its way to $40M based on only the company's current cash on hand. We are not concerned about dilution because if AIDX were to announce that it raises US$150 million in the upcoming weeks, most of that cash would be spent on rolling up additional AI start-ups.

AIDX Chairman Hamed Shahbazi, the Elon Musk of AI, is replicating exactly the same strategy that he used to rapidly build Well Health (TSX: WELL) into a $1.29 billion enterprise value company. Between August 2017 and February 2021, WELL saw its share price increase by 8,845%.

As of today, AIDX hasn't even reached the market cap of what Hamed Shahbazi's first start-up company Tio Networks was acquired for when PayPal paid $304 million for it in 2017. Elon Musk also sold his first company to PayPal. Obviously, Hamed Shahbazi could himself become a billionaire very soon, but if you search for Well Health and Li Ka-shing who is worth over $37 billion, you will see that Li Ka-shing was one of Hamed's earliest investors. Li Ka-shing made his first investment into Well Health on April 24, 2018, at a price of $0.33 per share, and made many additional investments into Well Health as its stock soared to a record high in 2021 of $9.84 per share.

Li Ka-shing in early-2023 invested big into German AI Healthcare start-up Doctorly GmbH (Europe's most promising AI healthcare company) and convinced Well Health to invest alongside him. In late-2023, AIDX also purchased a significant stake in Doctorly GmbH while entering into a strategic alliance to bring AIDX's AI Decision Support to the European market. AIDX will be enabling Doctorly's rapidly expanding network of European healthcare providers to implement AIDX's exclusive AI Decision Support!

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA has received compensation from AIDX of US$50,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.